Pacific Hospital Supply Co., Ltd (4126.TWO)
TWD 87.8
(3.05%)
TWD 87.8
(3.05%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -307.54 Million TWD | -23.63% |
| 2022 | -248.76 Million TWD | -78.27% |
| 2021 | -139.54 Million TWD | -159.32% |
| 2020 | 235.24 Million TWD | -46.42% |
| 2019 | 439.07 Million TWD | 29.5% |
| 2018 | 339.05 Million TWD | 28.38% |
| 2017 | 264.1 Million TWD | 4.81% |
| 2016 | 251.99 Million TWD | 157.32% |
| 2015 | -439.59 Million TWD | 40.88% |
| 2014 | -743.61 Million TWD | 10.39% |
| 2013 | -829.86 Million TWD | -2.34% |
| 2012 | -810.89 Million TWD | -37.83% |
| 2011 | -588.35 Million TWD | -19.36% |
| 2010 | -492.94 Million TWD | -23.97% |
| 2009 | -397.63 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -287.45 Million TWD | 6.53% |
| 2024 Q2 | -375.95 Million TWD | -30.79% |
| 2023 Q2 | -328.08 Million TWD | 20.66% |
| 2023 Q3 | -77.91 Million TWD | 76.25% |
| 2023 FY | -307.54 Million TWD | -23.63% |
| 2023 Q1 | -413.51 Million TWD | -66.23% |
| 2023 Q4 | -307.54 Million TWD | -294.73% |
| 2022 Q1 | -172.06 Million TWD | -23.3% |
| 2022 FY | -248.76 Million TWD | -78.27% |
| 2022 Q4 | -248.76 Million TWD | -295.91% |
| 2022 Q3 | -62.83 Million TWD | 78.37% |
| 2022 Q2 | -290.44 Million TWD | -68.81% |
| 2021 Q3 | -343.54 Million TWD | -410.14% |
| 2021 Q1 | 156.94 Million TWD | -33.29% |
| 2021 Q2 | 110.77 Million TWD | -29.42% |
| 2021 Q4 | -139.54 Million TWD | 59.38% |
| 2021 FY | -139.54 Million TWD | -159.32% |
| 2020 FY | 235.24 Million TWD | -46.42% |
| 2020 Q3 | 440.72 Million TWD | 47.43% |
| 2020 Q4 | 235.24 Million TWD | -46.62% |
| 2020 Q1 | 414.65 Million TWD | -5.56% |
| 2020 Q2 | 298.93 Million TWD | -27.91% |
| 2019 Q2 | 656.14 Million TWD | -2.59% |
| 2019 Q1 | 673.59 Million TWD | 98.67% |
| 2019 FY | 439.07 Million TWD | 29.5% |
| 2019 Q3 | 791.89 Million TWD | 20.69% |
| 2019 Q4 | 439.07 Million TWD | -44.55% |
| 2018 Q4 | 339.05 Million TWD | -30.49% |
| 2018 Q3 | 487.77 Million TWD | 43.45% |
| 2018 FY | 339.05 Million TWD | 28.38% |
| 2018 Q1 | 359.55 Million TWD | 36.14% |
| 2018 Q2 | 340.02 Million TWD | -5.43% |
| 2017 Q4 | 264.1 Million TWD | -18.16% |
| 2017 Q3 | 322.72 Million TWD | 35.38% |
| 2017 Q2 | 238.38 Million TWD | 1.09% |
| 2017 FY | 264.1 Million TWD | 4.81% |
| 2017 Q1 | 235.8 Million TWD | -6.42% |
| 2016 FY | 251.99 Million TWD | 157.32% |
| 2016 Q4 | 251.99 Million TWD | 310.5% |
| 2016 Q1 | -414.66 Million TWD | 5.67% |
| 2016 Q3 | 61.38 Million TWD | 121.17% |
| 2016 Q2 | -290.02 Million TWD | 30.06% |
| 2015 Q4 | -439.59 Million TWD | -5.15% |
| 2015 FY | -439.59 Million TWD | 40.88% |
| 2015 Q3 | -418.05 Million TWD | 29.37% |
| 2015 Q2 | -591.89 Million TWD | 21.51% |
| 2015 Q1 | -754.08 Million TWD | -1.41% |
| 2014 Q1 | -695.89 Million TWD | 16.14% |
| 2014 FY | -743.61 Million TWD | 10.39% |
| 2014 Q2 | -763.72 Million TWD | -9.75% |
| 2014 Q4 | -743.61 Million TWD | -16.05% |
| 2014 Q3 | -640.79 Million TWD | 16.1% |
| 2013 Q2 | -928.53 Million TWD | -5.69% |
| 2013 FY | -829.86 Million TWD | -2.34% |
| 2013 Q1 | -878.5 Million TWD | -8.34% |
| 2013 Q3 | -734.46 Million TWD | 20.9% |
| 2013 Q4 | -829.86 Million TWD | -12.99% |
| 2012 Q4 | -810.89 Million TWD | -13.94% |
| 2012 Q1 | -647.13 Million TWD | -9.99% |
| 2012 Q2 | -795.33 Million TWD | -22.9% |
| 2012 Q3 | -711.66 Million TWD | 10.52% |
| 2012 FY | -810.89 Million TWD | -37.83% |
| 2011 Q2 | -594.56 Million TWD | -14.83% |
| 2011 Q1 | -517.77 Million TWD | -5.04% |
| 2011 Q4 | -588.35 Million TWD | -34.08% |
| 2011 FY | -588.35 Million TWD | -19.36% |
| 2011 Q3 | -438.79 Million TWD | 26.2% |
| 2010 Q4 | -492.94 Million TWD | 0.0% |
| 2010 FY | -492.94 Million TWD | -23.97% |
| 2009 FY | -397.63 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | -1.4 Billion TWD | 78.054% |
| Bioteque Corporation | -459.67 Million TWD | 33.094% |
| Chi Sheng Pharma & Biotech Co., Ltd | -261.04 Million TWD | -17.813% |
| Sunder Biomedical Tech. Co., Ltd. | 394.6 Million TWD | 177.939% |
| BenQ Medical Technology Corporation | 405.72 Million TWD | 175.803% |
| Unicon Optical Co., Ltd. | 41.06 Million TWD | 848.877% |
| Formosa Optical Technology Co.,Ltd. | 2.78 Billion TWD | 111.048% |
| Medeon Biodesign, Inc. | -1.19 Billion TWD | 74.173% |
| Concord Medical Co., Ltd. | 104.78 Million TWD | 393.516% |
| Crystalvue Medical Corporation | -248.31 Million TWD | -23.852% |
| Perfect Medical Industry Co., Ltd. | 50.55 Million TWD | 708.381% |
| ICARES Medicus, Inc. | -259.62 Million TWD | -18.457% |
| Lagis Enterprise Co., Ltd. | 87.79 Million TWD | 450.3% |
| Amed Co., Ltd. | 153.75 Million TWD | 300.031% |